Reported Earlier, Neogen Outlines Growth And Margin Expansion Strategy At 2026 Investor Day, Targeting High-Single-Digit To Low-Double-Digit Revenue Growth, High-50% Adjusted Gross Margin And 30% Adjusted EBITDA Margin By FY2031
10/8/2026
Impact: 70
Healthcare